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Summary 
The present study demonstrates that in vitro comparisons of delivery vehicles are reliable as long as one performs the studies on 
skin samples taken from the same cadaver section of skin. The in vitro rates of delivery of minoxidil and hydrocortisone from an 
ointment and a propylene glycol/ethanol/water vehicle through skin sections taken from the same and different cadaver abdomens 
are specifically compared. When tested on skins from 8 human cadavers, the fluxes of minoxidil suspended in the ointment ranged 
from 0.37 X 10-s mg/cm2/h to 9.2 x 10m5 mg/cm2/h, a 25fold spread, and the fluxes of minoxidil from the propylene 
glycol/ethanol/water vehicle ranged from 1.25 x lo-’ mg/cm2/h to 18.7 X 10m5 mg/cm2/h, a 15-fold spread. However, when the 
ratios of fluxes between these two formulations were calculated for individual subjects, the values ranged from 1.3 to 3.5 (only a 
3-fold spread). Four human cadaver sections were used to evaluate the delivery of hydrocortisone. The flux values ranged from 696 to 
1335 cpm/cm2/h for the ointment and 946 to 1291 cpm/cm2/h for the propylene glycol/ethanol/water vehicle (up to a 2-fold 
spread). When the ratios of fluxes between these two formulations were calculated for each individual subject, the values ranged from 
0.96 to 1.39. The results with these two compounds suggest that even in the unavoidable presence of large inter-subject variations in 
the cadaver skin, the influence of vehicle on drug delivery performance can be determined. In addition to these findings concerning 
intra-subject variability, it was observed that the flw of minoxidil from the ointment attains a steady-state after an initial lag period 
of between 6 and 8 h but steady delivery is not apparent for the minoxidil solution, suggesting that for the solution formulation the 
thermodynamic activity of. the drug changes markedly as the experiment proceeds. No comparable curvature is seen for the 
hydrocortisone solution presumably because its thermodynamic activity is little changed during the vehicle’s evaporation. 
Introduction formance of a series of topical formulations can 
be compared by an in vitro technique. Of impor- 
As previously shown (Chiang et al., 1988), un- tance, formulation comparisons were based on 
der rigorously defined conditions the delivery per- data obtained from human cadaver membranes 
prepared from a single section of skin because a 
number of previous studies had shown that the 
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1984). Since a given sample of cadaver skin is 
limited in size, it is obviously impossible to com- 
pare a series of formulations using a single section 
of skin. Moreover, it remains uncertain whether 
one can generalize results obtained within a piece 
of skin. 
The purpose of this study is to determine if, in 
spite of large inter-subject variations in flux rates 
of a given drug in a given formulation, reliable in 
vitro appraisals of the influences of formulation 
on drug delivery are possible, provided one per- 
forms the studies on closely paired skin samples 
taken from the same cadaver section. An attempt 
is also made to see if parallel trends in the per- 
meation of a drug from a series of formulations 
exist across skins from different subjects. In order 
to fairly assess these two points, the fluxes of 
minoxidil and hydrocortisone from two formula- 
tions, a propylene glycol/ethanol/water solution 
and an ointment, have been evaluated using dif- 
ferent human cadaver skin samples. 
Materials and Methods 
Materials 
Minoxidil, USP milled, was supplied by the 
Upjohn Co. (Kalamazoo, MI). The [pyrirnidine-2- 
“C]minoxidil was obtained from the same source 
with a radiochemical purity of 99% and a specific 
activity of 15.79 mCi/mmol. [1,2-3H[Hydrocorti- 
sone (Amersham, Arlington Height, IL) had a 
radiochemical purity of 97% and a specific activity 
of 45 Ci/mmol. The mineral oil (Mallinkrodt, 
Paris, KY), white petrolatum (CMC, Smyrna, TN) 
and white wax required to prepare the ointment 
were used as received. All other chemicals used 
were reagent grade. 
Preparation of minoxidil and hydrocortisone formu- 
lations 
A recrystallized mixture of radiolabelled and 
cold minoxidil was prepared by the following pro- 
cedure. About 10 mg of [t4C]minoxidil was mixed 
together with unlabeled minoxidil (about 200 mg) 
in a 200 ml flask and 6 ml warm ethanol solution 
were added to dissolve the mixture. Hexane (about 
160 ml) was then added to initiate the recrystalli- 
zation of the minoxidil. The flask was chilled in an 
ice bath for 4 h and the recrystallized minoxidil 
powder was collected under vacuum filtration and 
placed in a desiccator overnight to facilitate re- 
moval of the solvent. The resultant recrystallized 
minoxidil had a specific activity of about 3 pCi/ 
mg. 
The ointment base was prepared from petro- 
latum/mineral oil/white wax (50 : 45 : 5, w/w) by 
heating these components at 65°C and stirring 
the melt until the preparation cooled and con- 
gealed. The solution vehicle was prepared by mix- 
ing propylene glycol/ethanol/water (20 : 63.2 : 
16.8, v/v). Since the amount of radiolabelled 
minoxidil available was limited, the 2% minoxidil 
ointment was prepared by incorporating the re- 
crystallized minoxidil into a suitable amount of 
the ointment contained on a watch glass with the 
aid of a small pestle. The 2% minoxidil solution 
was prepared by incorporating recrystallized mi- 
noxidil into a suitable volume of the vehicle. 
In a number of the experiments, small amounts 
of labeled hydrocortisone (approximately 3 PCi) 
were incorporated into the two different minoxidil 
formulations. The quantities of this drug were 
kept small to ensure that its solubility was not 
exceeded in either formulation. 
Permeation studies 
Abdominal skin obtained from 8 Caucasian 
human cadavers with an average age of 62 years 
was used. The abdominal site was chosen because 
it is expansive and because it has been reported to 
be less variable in permeability than other body 
sites (Southwell et al., 1984). No attempt was 
made to determine whether age influenced the 
permeation of drugs from the formulations tested. 
The skin samples (about 200 pm in thickness) 
were harvested as thin sheets with the aid of a 
dermatome. They were stored at - 10” C in a 
freezer prior to use. The frozen skins were thawed 
before use and cut into 4 cm’ sections. Depending 
upon the size of the skin sample acquired, ap- 
proximately 5-10 membranes could be prepared 
for mounting into diffusion cells. 
For determining the permeation of drugs from 
the ointment, the thin film application technique 
previously described by Chiang et al. (1988) was 
used. Briefly, a section of skin was placed on a 
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larger piece of Parafilm with the stratum comeum 
facing upwards. A template (200 pm thick brass 
disc of diameter 3.1 cm with a hole of diameter 1.4 
cm cut in the center) was put on top of the skin 
sample and the ointment was applied to the surface 
of the stratum comeum and troweled flush with 
the edge of the template with the aid of the 
straight edge of a square cover glass. The template 
was then carefully removed and the skin mem- 
brane was mounted on a Franz diffusion cell 
(Crown glass, Somerville, NJ) with the formula- 
tion exposed. The receiver compartment was filled 
with pH 7 phosphate buffer and maintained at 
37” C with a jacket of circulating water. The re- 
ceiver was continuously stirred with a bar magnet. 
For the permeation of drugs from solution, an 
appropriately sized section of skin was cut and 
directly mounted in a Franz diffusion cell with the 
stratum comeum facing upwards. After the re- 
ceiver compartment was filled with phosphate 
buffer to the predetermined operational level, 80 
~1 of the drug containing vehicle were applied to 
the skin surface with a micropipet. 
The moment a skin membrane with the oint- 
ment was properly positioned and the moment of 
applying an aliquot of the solution formulation 
marked the “zero time” for each run. At prede- 
termined time intervals, 0.6 ml samples were 
withdrawn from the receiver compartment by a 
l-ml tuberculin syringe fitted with a 23-gauge 
needle in turn fitted with a section of PE-50 
polyethylene tubing. Each sample removed was 
replaced with an equal volume of phosphate buffer. 
Exactly 0.5 ml of each sample were pipetted into 
10 ml liquid scintillation fluid (Safety Solve, RPI, 
Mount Prospect, IL) and assayed on a scintillation 
counter. 
Analysis of data 
After correction for the dilution of sampling, 
the data were plotted as the cumulative amount 
collected in the receiver compartment as a func- 
tion of time. The flux into the receiving reservoir 
in the quasi-steady-state is equal to: 
where J is the total pseudo-steady-state flux 
(mg/cm*/h) across the skin; A is the area for 
diffusion (cm*); V is the volume of the receiver 
compartment (ml); and dC/dt is the steady-state 
slope (mg/ml/h). Slopes were calculated using 
least-squares linear regressions of the apparent 
steady-states in, and around the 24 h point for the 
hydrocortisone formulations and for the minoxidil 
ointment. To gain working estimates of the fluxes 
from minoxidil solutions, the fluxes were esti- 
mated from the slopes of statistically drawn 
straight lines through all data points on the curvi- 
linear profiles between 8 and 24 h. Generally, data 
past 24 h were only included in the calculation of 
fluxes if they fell on steady-state portions of the 
profiles begun within the first 24 h. This placed a 
very conservative bias on the estimated fluxes 
from minoxidil solutions. 
Results 
Representative permeation profiles of minoxidil 
and hydrocortisone from the ointment and solu- 
tion vehicles are shown in Figs. 1 and 2, respec- 
tively. It can be seen that after an initial lag 
period, the drugs permeated the skin from both 
vehicles in easily measured amounts. The permea- 
tion rates of both drugs attained steady levels 
Time (hr) 
Fig. 1. Representative plots of permeation of 2% minoxidil 
from ointment and solution vehicles through human cadaver 
skin. 
J=-” dc 
A ’ dt 
10 20 30 
Time (hr) 
Fig. 2. Representative plots of permeation of tracer hydrocorti- 
sane from ointment and solution vehicles through human 
cadaver skin, 
from the ointment. The solution vehicle, however, 
gave curvilinear profiles with particularly striking 
curvature in the case of minoxidil. For hydrocor- 
tisone formulations and minoxidil in the ointment, 
TABLE 1 
Fluxes of minoxidil (2%) and hydrocortisone (trace amounts) 
from solution and ointment vehicles through human cadaver skin 
determined by finite dose experiments 
Cadaver Ointment Solution 
no. 
Flux of minoxidil (X IO5 mg/cm’/h) 
1 0.51 a 1.3zto.43 
2 0.37 (0.38,0.37) ’ 1.3+0.1 
3 2.2 * 0.97 c 7.3 + 3.3 
4 7.8f2.67 10.01t2.8 
5 1.6 (2.5,0.70) 4.4 (4.9, 3.8) 
6 9.2 +_ 2.0 18.7+2.0 
7 3.8kO.38 9.0 f 2.4 











Mean + S.D. 2.650.7 
Flux of hydrocortisone (epm /cm ‘/h) 
2 983 + 235 946+ 83 1.0 
3 696 + 269 966 f 337 1.4 
4 1335 f 2.70 1291+ 477 1.0 
6 991 k 243 1166+ 72 1.2 
Mean f S.D. 1.1*0.2 
a Single experiment. 
b Mean with individual values in parentheses; 2 experiments. 
’ Mean f SD.; 3 or more experiments. 
the best straight line possible was drawn through 
the data to the end of the experiments at 32 h. 
Since a steady-state region was not apparent for 
the minoxidil solution permeation curves, the 8-24 
h region was used to generate functional flux 
values. Earlier time points were passed over to 
recognize the lag time and later time points were 
discarded as being impractically long. 
The fluxes for minoxidil and hydrocortisone 
from the two formulations calculated as described 
above and the calculated ratio of the fluxes for 
each drug from these two formulations are listed 
in Table 1. 
Discussion 
As previously demonstrated (Chiang et al. 
1988) in vitro drug delivery discrimination is pos- 
sible using 3 semi-solid topical formulations ap- 
plied to a section of skin obtained from a single 
cadaver. However, there is a limit to the amount 
of information which can be gathered on a single 
sample of skin and one may question the repre- 
sentativeness of results and rankings established 
with skin from a single source. Since the work 
reported by Shaw et al. (1980) and Southwell et al. 
(1984) suggest that flux values obtained on skin 
samples from different donors likely do not pro- 
vide valid comparisons and given the sparseness 
of credible data, in vitro methods to evaluate 
topical drug delivery can be called into question 
despite the fact that, in principle, the methods 
should be discerning. These issues are addressed 
in the present study. 
The flux of minoxidil from the ointment (Fig. 
1) attains a steady-state after an initial lag period 
of between 6 and 8 h. However, steady delivery 
(throughput) is not apparent for the minoxidil 
solution. The steady-state for the ointment was 
not unexpected since minoxidil was present in 
amounts greatly exceeding its solubility in the 
vehicle and since the vehicle is compositionally 
stable during the course of the experiment. On the 
other hand, for the minoxidil solution formula- 
tion, the concentration of drug and composition 
of solvents vary systematically upon application to 
the skin. Hence, the thermodynamic activity of the 
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drug would be expected to radically change over 
the course of an experiment. Specifically, the 
vehicle composition varies as the alcohol and water 
evaporate in accordance with their respective vapor 
pressures. In fact, when the alcohol evaporates 
(within a few hours), the resultant solution is at or 
possibly slightly above its saturation value (pre- 
cipitation of drug can be brought about by seed- 
ing a 3-5% solution under identical conditions). 
Comparable continuous curvature is not seen for 
the hydrocortisone solution apparently because 
the thermodynamic activity remains about the 
same even during the vehicle’s evaporation since 
extremely dilute solutions were used (trace 
amounts). 
For the 8 human cadaver abdominal skin sec- 
tions studied, the flux of minoxidil from the oint- 
ment varied from 0.37 x 10e5 mg/cm’/h to 9.2 x 
10e5 mg/cm*/h, a 25-fold spread (Table 1). The 
fluxes of minoxidil from the solution vehicle varied 
from 1.25 X 10K5 mg/cm*/h to 18.7 x lop5 
mg/cm2/h, a 15-fold spread. The minoxidil flux 
data were evaluated statistically utilizing two-fac- 
tor analysis of variance (ANOVA). Differences 
between formulations and among cadavers were 
significant (P < 0.0001 for each effect). These dif- 
ferences, however, could not be legitimately 
evaluated due to the presence of a significant 
interaction between the two factors (P < 0.034). 
The presence of interaction was not unexpected as 
the minoxidil ointment and solution flux ratios 
(rather than flux differences) tended to be con- 
stant across cadavers. Ratios of the average for- 
mulation flux values, when calculated across 
cadavers (see Table l), varied from 1.29 to 3.52 
(only a 3-fold spread). A logarithmic transforma- 
tion of the data yielded a two factor ANOVA 
model in which the cadaver/formulation interac- 
tion term was not significant (P > 0.3). Hence, the 
cadaver and formulation main effects could be 
appropriately evaluated. Differences among 
cadavers and between formulations were signifi- 
cant (P < 0.001 for each effect.). 
The flux of hydrocortisone from the ointment 
varied from 696 cpm/cm*/h to 1355 cpm/cm*/h, 
a two-fold spread, using the 4 human cadaver 
abdominal skin samples studied. The fluxes of 
hydrocortisone from the solution vehicle varied 
from 946 cpm/cm2/h to 1291 cpm/cm*/h, a 1.4- 
fold spread. Statistical analysis of the hydrocorti- 
sone flux data by two-factor ANOVA indicated 
that differences between formulations were not 
significant (P > 0.4) but that differences among 
cadavers were significant (P < 0.03). The ratios of 
average hydrocortisone flux values, when calcu- 
lated across cadavers (see Table l), varied from 
0.96 to 1.39, suggesting little difference between 
formulations. 
These results suggest that a large degree of 
inter-cadaver variation in in vitro flux can exist 
for certain compounds. In light of this, the evalua- 
tion of formulation differences may be impossible 
for these compounds, unless comparisons are made 
within sets of skin sections taken from the same 
cadaver. Using our previously described experi- 
mental technique, formulations which differed in 
in vitro flux by a factor as small as 2 or 3 were 
successfully evaluated, and hence it is possible to 
grade the performance of topical formulations. 
This can be best achieved by including a reference 
standard formulation, evaluated in a matched piece 
of skin from the same cadaver, in each evaluation 
of a test formulation. The average flux value of 
the test formulation can then be expressed relative 
to the average flux value for the reference formu- 
lation. This ratio appears to be independent of the 
cadaver skin sample utilized, and hence can be 
used to compare a given test formulation against 
the relative flux values of other test formulations 
studied in a similar manner. 
Finally, it should be pointed out that a consid- 
erable degree of arbitrariness is associated with 
the evaluation of data as these. For instance, the 
above comparisons are based on effective fluxes of 
the permeants achieved in the 8-24 h period of 
the experiments. Had the cumulative amount de- 
livered in a fixed time, i.e. for 12 h, been chosen as 
the indicator of delivery, one might conclude that 
the minoxidil formulations but not the hydrocorti- 
sone formulations were comparable in delivery 
(see Figs. 1, 2). Putting the delivery in terms of the 
amount accumulated in any fixed point in time 
suffers from the problem that variation in lag time 
distorts the delivery comparison even more than 
the failure to achieve a steady state flux tends to 
distort it. Thus, as long as lag times are on the 
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short side of a period of application which is 
clinically realistic, here judged to be 24 h, fluxes 
seem to offer the more telling indication of rela- 
tive delivery merit. Comparisons of fluxes or any 
other measures of delivery based on times far 
exceeding 24 h raise serious questions because 
such periods seem unrealistically long relative to 
the normal patterns of use of ointment and creams. 
It should be noted that in the present case with 
curvilinear data, had any other reasonable method 
been used to estimate fluxes, i.e. the instantaneous 
slope at 24 h or use of late developing (post 24 hr) 
steady-states, differences in delivery would have 
been unduly exaggerated. 
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